Abstract
Phytophenols are found ubiquitously among all plants. They are important in diets rich in fruits and vegetables because these compounds provide health benefits to the host, ultimately decreasing the incidence of chronic diseases. These compounds act as natural antioxidants and provide anti-inflammatory, antiviral, antibiotic, and antineoplastic properties. Reactive oxygen species (ROS) are produced under normal physiological functions, and low/moderate levels are required for cellular turnover and signaling. However, when ROS levels become too high, oxidative stress can occur. Phytophenols quench ROS and ultimately avoid the damaging effects ROS elicit on the cell. The highest source of bioavailable phytophenols comes from our diet as a component usually esterified in plant fiber. For phytophenols to be absorbed by the body, they must be released by esterases, or other related enzymes. The highest amount of esterase activity comes from the gastrointestinal (GI) microbiota; therefore, the host requires the activity of mutualistic bacteria in the GI tract to release absorbable phytophenols. For this reason, mutualistic bacteria have been investigated for beneficial properties in the host. Our laboratory has begun studying the interaction of Lactobacillus johnsonii N6.2 with the host since it was found to be negatively correlated with type 1 diabetes (T1D). Analyses of this strain have revealed two important characteristics: (1) It has the ability to release phytophenols from dietary fiber through the secretion of two strong cinnamoyl esterases and (2) L. johnsonii also has the ability to generate significant amounts of H2O2, controlling the activity of indoleamine 2,3-dioxygenase (IDO), an immunomodulatory enzyme.
Keywords
- Lactobacillus
- Lactobacillus johnsonii N6.2
- Indolamine 2
- 3-dioxygenase
- 5-hydroxytryptamine
- reactive oxygen species
- esterase
1. Phytophenols
Phytophenols, also called polyphenols or simply phenols, are a unique group of monocyclic and polycyclic phytochemicals found within fruits, vegetables, and other plants as a component of plant fiber. Phytophenols are ubiquitously found as secondary metabolites in plants and are therefore consumed in relatively high quantities. They are a very diverse and multi-functional group of active plant compounds with substantial health potential in many areas, and numerous scientific studies demonstrate that increasing the intake of plant foods rich in fiber can minimize the incidence of modern diseases [1–3].
Consumption of foods and beverages containing phytophenols may impact nutrient levels in the body by preventing their oxidation. Their activity is based on functional groups’ capacity to accept a free radical’s negative charge [4, 5]. In order to be absorbed by intestinal epithelial cells, phytophenols attached to fiber can only be released by the enzymatic activities of the gastrointestinal (GI) microbiota [6–9] because the phenolic esterase enzymes necessary to release antioxidant phytophenols from plant fiber are not produced by the host GI system. It has been shown
All phytophenols arise from a common intermediate, phenylalanine, or a close precursor, shikimic acid [14]. Often they are present in conjugated forms, with sugar residues linked to hydroxyl groups, although in some cases, direct links of the sugar to an aromatic carbon do exist. In addition, associations with other compounds are also common, including linkages with carboxylic and organic acids, amines, and lipids, as well as associations with other phenols [15].
Plants produce an impressive array of phenolic compounds, and it is thought that these plant-based constituents have a stronger biological antioxidant effect when compared to synthetic antioxidants. This is mainly because phytophenols are part of the normal function of living plants and therefore are thought to have better compatibility with the body [4, 16, 17]. Although there are more than 8000 identified polyphenolic compounds, they can be sorted into four main classes: phenolic acids, flavonoids, stilbenes, and lignans [18]. Figure 1 illustrates the different groups, which are divided by the number of rings they contain as well as the structural elements that bind these rings together.
Phenolic acids are derivatives of either benzoic acid or cinnamic acid and can thus be divided into two classes. They make up about a third of the polyphenolic compounds found in human diets. These phenolic compounds can be found in all plant-based material, although they are most commonly found in acidic fruits [19]. Flavonoids are the most abundant polyphenolic compounds found in our diet and are also the most well-studied group. More than 4000 varieties have been accounted for, often contributing to the color of flowers, fruits, and leaves [20]. Six subclasses exist, as shown in Figure 2, based upon variations in structure: flavonols, flavones, flavanones, flavanols, anthocyanins, and isoflavones.
Stilbenes contain two phenyl moieties connected by a two-carbon methylene bridge. Their synthesis is typically initiated as a result of injury or infection in plants, and as a consequence, their occurrence in our diet is much lower than either phenolic acids or flavonoids. The best studied stilbene is resveratrol, found mainly in grapes and as a result also in red wine. Lignans are diphenolic compounds formed by the dimerization of two cinnamic acid residues, as seen in Figure 1.
Estimating the total polyphenol content is most accurately done through analysis of every individual phytophenolic compound. Due to the large diversity in phytophenolics, the only way to complete this task is through a compilation of the literature data. Fortunately, the USDA database contains a nearly complete source of food composition data [21–23]. This database combined with other literature sources for the remaining phytophenolic compounds was used to develop the Phenol-Explorer database. This recently developed database is the most complete source on the content of polyphenols in foods, including glycosides, esters, and aglycones of flavonoids, phenolic acids, lignans, stilbenes, and other polyphenols [24].
The occurrence of dietary phenolics in plants is not uniform, even at the cellular level. Insoluble phytophenols are often found in cells walls, while soluble phytophenols are found within the vacuoles of plant cells [25]. In many instances, plant-based foods contain a variable mixture of polyphenols. Some polyphenols, such as flavanones and isoflavones, are found only in specific foods, whereas others such as quercetin are found in nearly all plant products. Conventionally, the outer tissues of a plant contain higher levels of phenolics than the inner tissues [26].
Various other factors can affect the concentration of dietary phytophenols, including ripeness of the plant when harvested, environmental factors, storage, and processing of plant materials [14]. Before harvesting, abiotic factors such as soil type, exposure to sunlight, and amount of rainfall can alter phenolic compounds in plants. In addition, the degree of ripeness when harvested can be positively or negatively correlated with the concentration of polyphenols, depending upon which compound is under observation [27]. Storage of plant-based foods also affects polyphenol levels, and the oxidation of polyphenols over time can be beneficial (as in the case of black tea) or harmful (as in the case of browning of fruit) to polyphenolic compound concentrations [27]. Cooking also has a major effect on phytophenolic compounds, and depending on how the material is processed, cooking may account for a 30–80% loss of phenolic content [28].
Bioavailability is described as the proportion of the nutrient that follows natural pathways to be digested, absorbed, and metabolized in the body. For phytophenols, there is no relationship between the quantity of phenolic compounds found in food and their bioavailability, and every one of the numerous known polyphenols differs in its bioavailability. Furthermore, the most ubiquitous phytophenols found in plant-based foods are not necessarily the same as those that show the highest concentration of metabolites in tissues. Often, polyphenols are present in a form that cannot directly be absorbed by the body, including esters, glycosides, or polymers [29]. Due to the microbial modification of phytophenols during absorption in the intestinal cells and later in the liver, the compounds reaching the bloodstream and bodily tissues are drastically different from those originally ingested. As a consequence, identifying all the metabolites and subsequently evaluating their activity is a difficult task. It is the chemical structure of the phytophenolic compound that determines absorption rate and extent rather than the concentration of the compound found in the diet [30]. Evidence does indirectly suggest that phenols are absorbed to some extent through the gut barrier due to an increase in antioxidant capacity of plasma after ingestion of phytophenol-rich foods [31, 32].
The potential pharmacological properties of these natural plant compounds have been demonstrated
ROS are the by-products of cellular redox processes in the body. These free radical compounds contain one or more unpaired electrons in their outer orbit, creating instability that leads to significant reactivity. ROS species include superoxide (O2•−), hydroxyl (•OH), peroxyl (ROO•), lipid peroxyl (LOO•), and alkoxyl (RO•) radicals. Oxygen free radicals can also be converted to other non-radical reactive species, which are dangerous for health due to their tendency to lead to free radical reactions in living organisms. These species include hydrogen peroxide (H2O2), ozone (O3), singlet oxygen (1/2O2), and hypochlorous acid (HOCl). ROS are capable of modifying structural proteins or inactivating enzymes, and as a consequence disrupting normal physiologic functions in the body [42–44]. Production of free radicals is a normal part of our physiology and occurs continually to keep the body functioning properly. Processes that generate ROS include activities of the immune system, metabolism, and inflammation responses, along with stress, pollution, radiation, diet, toxins, exhaust fumes, and smoking. [4, 16, 42, 45].
Excessive production of ROS can easily overwhelm both the enzymatic and non-enzymatic antioxidant defense systems, leading to oxidative stress and inflammation. It has been widely discussed in scientific literature that increasing the intake of natural antioxidants minimizes the deleterious effects of ROS [34, 46–48]. Evidence collected from feeding assays using diets rich in antioxidant plant phenolics supports this claim [2, 7, 49]. The intake of phytophenols has been shown to minimize the production of ROS and mitigate their harmful impact on the GI system [3, 33, 50].
Oxidative stress leads to disease through four destructive pathways: membrane lipid peroxidation, protein oxidation, DNA damage, and disturbance of reducing equivalents in the cell [4]. These steps often lead to altered signaling pathways and cell destruction. Oxidative stress has been connected to various diseases such as cancer, cardiovascular diseases, neurological disorders, diabetes, and aging. Each molecule in the body is at risk of damage by ROS, and damaged molecules can impair cellular functioning and lead to cell death, which ultimately results in diseased states [43, 44, 51]. Due to the antioxidant properties of phytophenolic compounds, they are associated with the prevention of a large array of diseases, including cardiovascular disease, cancer, diabetes, rheumatoid arthritis, neurodegenerative diseases, GI diseases, renal disorders, pulmonary disorders, eye disorders, infertility, and pregnancy complications, as well as slowing the progression of aging [4].
Although reduction of ROS has been shown to decrease risk of a huge array of diseases, the classical model of ROS generation and resulting oxidative stress contrasts with some emerging scientific evidence. Benefits of ROS can in fact occur when these species are present in low/moderate concentrations, as part of normal physiological functions [43]. The majority of cells produce superoxide and hydrogen peroxide constitutively, while other cells possess inducible ROS release systems. Beneficial effects can include defense against infectious agents by phagocytosis, killing of cancer cells by macrophages and cytotoxic lymphocytes, detoxification of xenobiotics by Cytochrome P450, generation of ATP in mitochondria (energy production), cell growth, and the induction of mitogenic responses at low concentrations. ROS also plays a role in cellular signaling, including activation of several cytokines and growth factors, non-receptor tyrosine kinase activation, protein tyrosine phosphatase activation, release of calcium from intracellular stores, and activation of nuclear transcription factors. ROS can also initiate vital actions such as gene transcription and regulation of soluble guanylate cyclase activity in cells [44, 50].
Reactive oxygen species (ROS) are known to play a dual role in biological systems; they are well documented for playing a role as both deleterious and beneficial species [43, 44, 52]. We hypothesize that redox homeostasis in the GI tract is dependent on the dynamic interplay between the generation of ROS and the ROS quencher ability of antioxidant phytophenols released by intestinal microbes. Although there are possible benefits to maintain low levels of ROS in the proper functioning of the body, the diet and lifestyle of the majority results in increased levels of ROS in the body are known to be harmful and can lead to the progression of disease. In this way, it is critical to maintain the proper balance of ROS in the body, and phenolic compounds have been shown to reestablish a healthy level of ROS. Next, we turn to the vital interaction of phytophenols and microflora of the gut system that can lead to creation of redox balance critical to health.
2. Lactic acid bacteria
The group known as lactobacilli is composed of several genera of bacteria (
The
The extensive use of these bacteria in food and beverage industries drove the scientific attention toward the evaluation of their impact on health, mainly on the GI system’s integrity and responsiveness. Regardless, lactic acid bacteria were safely used for centuries to modify food flavor and texture, modern genomics bring back to light the scientific discussion toward their impact on human health [54, 58].
Studies of the human microbiome revealed that lactobacilli could occupy different microhabitats in the human body, such as the buccal cavity and nasal fossa, but they mainly thrive in the gut and the urogenital tract [59]. In women, it was observed that variations of estrogen and glycogen stimulates the growth of lactic acid bacteria. Depletion of vaginal lactobacilli could give rise to adverse microbial flora colonization inducing urogenital infection [60]. Gustafsson
Lactobacilli are excellent organic acid producers, converting sugars into lactic acid and other by-products such as acetate, ethanol, CO2, butyrate, and succinate. They produce small molecules, as well, such as H2O2, or compounds such as diacetyl, or acetaldehyde [67]. Several of these metabolites are bioactive, with beneficial effects for the human GI. At the same time, they are essential for the dairy industry because they provide flavoring and display natural preservative properties [68]. They help to maintain the integrity of GI layers, favoring the renewal of the epithelium. A continuous renewal of the GI layers is critical to maintain an adequate barrier function to minimize several significant human diseases, including autoimmunity and cancer. According to recently published studies, the production of low amounts of H2O2 at the GI level is beneficial to the host. Besides its well-characterized antimicrobial activity, this molecule could directly down-regulate the early stages of the host inflammatory response and improve epithelial cell restitution and healing via the oxidation of cysteine residues in the host tyrosine phosphatases [62, 69].
Other important metabolites synthesized by
Maintenance of the GI redox homeostasis is essential in minimizing human diseases. The production of enzymes, which could increase the amount of free and active antioxidant agents in the GI lumen, is another important characteristic associated with several
The released monophenols (caffeic acid or other cinnamic acids) may exert its biological activities on the host, either at the level of the colonic mucosa itself, or in other tissues and organs, possibly after further modification by mammalian enzymes in the liver [80]. The release and solubilization of these phenolics, from fiber, also favor its absorption and further modification by other GI commensals.
The capacity of lactic acid bacteria to transform phenolic compounds into smaller novel molecules able to be absorbed in the GI system reoriented modern research to use combinations of probiotics and prebiotic products together. A large variety of dietary fibers were used for this purpose. Yet, the microbial metabolism of the released compounds by different bioconversion pathways, such as glycosylation, deglycosylation, ring cleavage, methylation, glucuronidation, and sulfate conjugation, depends on the microbial strains and substrates used. The results of such combinations are a large array of new metabolites, many of them recognized as bioactive molecules. This strategy demonstrates to have the potential to produce extracts with a high-added value from plant-based matrices (soybean, apple, cereals, among others).
Studies of apple juice fermentation to manage hyperglycemia, hypertension, and modulation of microbiota composition were also carried out. Apple juice, fermented by
The benefits of
The ability of lactic acid bacteria to metabolize dietary phytophenols prompts the use of new component combinations in fermented products. Several of these new blends were formulated with plant extracts rich in aromatic compounds. Example of this is the addition of green tea in bioyogurts fermented with selected lactic acid bacteria. Species such as
3. A model case study, Lactobacillus johnsonii N6.2
The intestinal epithelium is one of the most immunologically active surfaces of the body due to the high abundance of microbes and food antigens that are constantly exposed to the GI system. The mucosal surface of the intestinal epithelium is the first line of defense from invading pathogens in the GI tract. Breaching this barrier and subsequently activating aberrant immune signaling have been involved in many diseases, both locally and systematically related. In this context, it has been proposed that there is a complex interplay between gut resident microbiota [95, 96], gut permeability [97], and altered immune function in the development of type 1 diabetes [98].
Currently, our scientific efforts are directed on characterizing a strain of
As it was described before, the release of antioxidant compounds by probiotic bacteria is relevant since an enhanced oxidative stress response triggered by the excessive production of reactive oxygen species is observed in T1D and other diseases [105–107]. This characteristic was relevant in the study because a low dosage of ferulic acid stimulates the release of insulin and alleviates symptoms common to T1D in rodents [83, 108, 109]. Therefore, it would seem plausible that orally administering lactic acid bacteria containing CE qualities would help reduce blood glucose levels and ultimately prevent the onset of diabetes. To confirm this, a feeding experiment of
As it was observed that an altered intestinal microbiota was associated with diabetes onset, as previously suggested [95, 96], gut permeability and barrier function were investigated next between
Among the destructive properties of reactive oxygen species (ROS) generated during early disease development is its ability to disrupt the function of epithelial tight junction proteins [113]. To determine the extent of the oxidative stress environment, ileal mucosal hexanoyl-lysine levels were quantified by ELISA and a significant increase of levels was observed in diabetic animals when compared to healthy controls and
Since it has been determined that
As more is studied about
After experiencing reduced kynurenine production and IDO inhibition in response to
Figure 4 most accurately summarizes the work our group has done in characterizing
Although
Acknowledgments
This material is based upon work that is supported by the National Institute of Food and Agriculture, US Department of Agriculture, under award number 2015-67017-23182, and Juvenile Diabetes Research Foundation under award number 1-INO-2014-176-A-V.
References
- 1.
Zamora-ros R, Cherubini A, Urp M, Bandinelli S, Ferrucci L, Andres-lacueva C. High concentrations of a urinary biomarker of polyphenol intake are associated with decreased mortality in older adults. J Nutr. 2013;143:1445–50. - 2.
Sansbury LB, Wanke K, Albert PS, Kahle L, Schatzkin A, Lanza E. The effect of strict adherence to a high-fiber, high-fruit and -vegetable, and low- fat eating pattern on adenoma recurrence. Am J Epidemiol. 2009;170(5):576–84. - 3.
Davis CD, Milner JA. Gastrointestinal microflora, food components and colon cancer prevention. J Nutr Biochem. 2009;20(10):743–52. - 4.
Sen S, Chakraborty R. The role of antioxidants in human health. Oxidative Stress: Diagnostics, Prevention, and Therapy; 2011. p. 1–37. - 5.
Watson R, Preedy V, Zibadi S. Polyphenols in Human Health and Disease. 1st ed. London: Academic Press; 2013. 1488p. - 6.
Kin KL, Lorca GL, Gonzalez CF. Biochemical properties of two cinnamoyl esterases purified from a Lactobacillus johnsonii strain isolated from stool samples of diabetes-resistant rats. Appl Environ Microbiol. 2009;75(15):5018–24. - 7.
Topakas E, Vafiadi C, Christakopoulos P. Microbial production, characterization and applications of feruloyl esterases. Process Biochem. 2007;42(4):497–509. - 8.
Aura A-M. Microbial metabolism of dietary phenolic compounds in the colon. Phytochem Rev. 2008;7(3):407–29. - 9.
Russell W, Scobbie L, Chesson A, Richardson A, Stewart C, Duncan S, et al. Anti-inflammatory implications of the microbial transformation of dietary phenolic compounds. Nutr Cancer. 2008;60(5):636–42. - 10.
Sirianni R, Chimento A, De Luca A, Casaburi I, Rizza P, Onofrio A, et al. Oleuropein and hyrdroxytyrosol inhibit MCF-7 breast cancer cell proliferation interfering with ERK1/2 activation. Mol Nutr Food Res. 2010;54(6):833–40. - 11.
Ciafardini G, Marsilio V, Lanza B, Pozzi N. Hydrolysis of oleuropein by Lactobacillus plantarum strains associated with olive fermentation. Appl Environ Microbiol. 1994;60(11):4142–7. - 12.
Hlid RABEL, Respy VAC, Age NIP, Aab THR, Ansen CARLRIKH. Hydrolysis of rosmarinic acid from rosemary extract with esterases and Lactobacillus johnsonii in vitro and in a gastrointestinal model. J Agric Food Chem. 2009;57(17):7700–5. - 13.
Yang J, Zhang G, Tian J, Li C, Jiang W, Xing Y, et al. Cardioprotective effect of SMND-309, a novel derivate of salvianolic acid B on acute myocardial infarction in rats. Basic Clin Pharmacol Toxicol. 2009;317–23. - 14.
Pandey KB, Rizvi SI. Plant polyphenols as dietary antioxidants in human health and disease. Oxid Med Cell Longev. 2009;2(5):270–8. - 15.
Kondratyuk T, Pezzuto J. Natural product polyphenols of relevance to human health. Pharm Biol. 2004;42:46–63. - 16.
Sen S, Chakraborty R, Sridhar C, Reddy YSR, De B. Free radicals, antioxidants, diseases and phytomedicines: current and future prospect. Int J Pharm Sci. 2010;3(1):91–100. - 17.
Krishnaiah D, Sarbatly R, Bono A. Phytochemical antioxidants for health and medicine—a move towards nature. Biotechnol Mol Biol Rev. 2007;1(September):97–104. - 18.
Spencer JPE, Abd MM, Mohsen E, Minihane A, Mathers JC. Biomarkers of the intake of dietary polyphenols: strengths, limitations and application in nutrition research. Br J Nutr. 2008;44:12–22. - 19.
Shahidi F, Naczk M. Food Phenolics: Sources, Chemistry, Effects, Applications. Lancaster, PA: Technomic Publishing Co Inc; 1995. - 20.
Groot H De, Rauen U. Tissue injury by reactive oxygen species and the protective effects of flavonoids. Fundam Clin Pharmacol. 1998;12:249–55. - 21.
Human B, Rock L, Cranberries OS. USDA Database for the Proanthocyanidin Content of Selected Foods; 2004. - 22.
Bhagwat S, Haytowitz DB, Holden JM. USDA Database for the Flavonoid Content of Selected Foods; 2011. - 23.
Bhagwat S, Haytowitz DB, Holden JM. USDA Database for the Isoflavone Content of Selected Foods; 2008. - 24.
Neveu V, Perez-Jimenez J, Vos F, Crespy V, Du Chaffaut L, Mennen L. Phenol-Explorer: an online comprehensive database on polyphenol contents in foods. Databases. 2010. - 25.
Wink M. Campartmentation of secondary metabolites and xenobiotics in plant vacuoles. Adv Bot Res. 1997;25:141–69. - 26.
Gbmez-cordovi C, Estrella I, Fermentaciones I De, Csic I, Cierva CJ De, Madrid E-. Importance of phenolic compounds for the characterization of fruit juices. J Agric Food Chem. 1992;40:1531–5. - 27.
Manach C, Scalbert A, Morand C, Rémésy C, Jime L. Polyphenols: food sources and bioavailability. Am J Clin Nutr. 2004;79:727–47. - 28.
Crozier A, Lean MEJ, Mcdonald MS, Black C. Quantitative analysis of the flavonoid content of commercial tomatoes, onions, lettuce, and celery. J Agric Food Chem. 1997;45:590–5. - 29.
Archivio MD, Filesi C, Benedetto R Di, Gargiulo R, Giovannini C, Masella R. Polyphenols, dietary sources and bioavailability. Ann 1st Super Sanita. 2007;43:348–61. - 30.
Setchell K, Faughnan MS, Avades T, Zimmer-nechemias L, Brown NM, Wolfe BE. Comparing the pharmacokinetics of daidzein and genistein with the use of 13 C-labeled tracers in premenopausal women. Am J Clin Nutr. 2003;77:411–9. - 31.
Duthie G, Pederson M, Gardner P, Morrice P, Jenkinson A, McPhail D, et al. The effect of whisky and wine consumption on total phenolic content and antioxidant capacity of plasma from health volunteers. Eur J Clin Nutr. 1998;52:733–6. - 32.
Young JF, Nielsen SE, Haraldsdóttir J, Daneshvar B, Lauridsen ST, Knuthsen P, et al. Effect of fruit juice intake on urinary quercetin excretion and biomarkers of antioxidative` status. Am J Clin Nutr. 1999;69:87–94. - 33.
Edward WCÆ, Birch J. Radical scavenging activity of lipophilized products from transesterification of flaxseed oil with cinnamic acid or ferulic acid. Lipids. 2009;44(9):807–15. - 34.
Nanjundaiah SM, Nayaka H, Annaiah M, Dharmesh SM. Gastroprotective effect of ginger rhizome (Zingiber officinale) extract: role of gallic acid and cinnamic acid in H+, K+, -ATPase/H. pylori inhibition and anti-oxidative mechanism. Evid Based Complement Altern Med. 2009; - 35.
Moon D, Kim M, Lee J, Hyun Y, Kim G. Rosmarinic acid sensitizes cell death through suppression of TNF-a-induced NF-kB activation and ROS generation in human leukemia U937 cells. Cancer Lett. 2010;288(2):183–91 [Elsevier Ireland Ltd]. - 36.
Ding M, Yuan Y. Study on the mechanisms of an extract of Salvia miltiorrhiza on the regulation of permeability of endothelial cells exposed to tumour necrosis factor-a. J Pharm Pharmacol. 2007;59(7):1027–33. - 37.
Lee-huang S, Huang PL, Zhang D, Lee JW, Bao J, Sun Y, et al. Discovery of small-molecule HIV-1 fusion and integrase inhibitors oleuropein and hydroxytyrosol: part II. Integrase inhibition. Biochem Biophys Res Commun. 2009;354(4):872–8. - 38.
Bioactive berry compounds—novel tools against human pathogens. Appl Microbiol Biotechnol. 2005;67(1):8–18. - 39.
Crosier A, Jaganath I, Clifford M. Dietary phenolics: chemistry, bioavailability and effects on health. Nat Prod Rep. 2009;26(8):1001–41. - 40.
Omatsu T, Naito Y, Handa O. Involvement of reactive oxygen species in indomethacin-induced apoptosis of small intestinal epithelial cells. J Gastroenterol. 2009;44(19):30–4. - 41.
Suschek CV, Gummersbach C, Hemmrich K, Kro K, Fehsel K, Pallua N. New aspects of adipogenesis: radicals and oxidative stress. Differentiation. 2009;77(2):115–20. - 42.
Pham-huy LA, He H, Pham-huy C. Free radicals, antioxidants in disease and health. Int J Biochem. 2008;4(2):89–96. - 43.
Valko M, Leibfritz D, Moncol J, Cronin MTD, Mazur M, Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem. 2007;39:44–84. - 44.
Fang Y, Yang S, Wu G. Free radicals, antioxidants, and nutrition. Nutrition. 2002;18:872–9. - 45.
Sarma A, Mallick A, Ghosh A. Free radicals and their role in different clinical conditions: an overview. Int J Pharma Sci. 2010;1(3):185–92. - 46.
Jaganathan SK, Mandal M. Antiproliferative Effects of honey and of its polyphenols. J Biomed Biotechnol. 2009;8306–16. - 47.
Jemai H, El Feki A, Sayadi S. Antidiabetic and antioxidant effects of hydroxytyrosol and oleuropein from olive leaves in alloxan-diabetic rats. J Agric Food Chem. 2009;57(19):8798–804. - 48.
Mueller M, Lukas B, Novak J, Simoncini T, Genazzani A, Jungbauer A. Oregano: a source for peroxisome proliferator-activated receptor gamma antagonists. J Agric Food Chem. 2008;56(24):1621–30. - 49.
Tian J, Fu F, Li G, Wang Y, Gao Y, Liu Z, et al. SMND-309, a novel derivate of salvianolic acid B, ameliorates cerebral infarction in rats: characterization and role. Brain Res. 2009;1263:114–21. - 50.
Lu Y, Foo LY. Salvianolic acid L, a potent phenolic antioxidant from Salvia officinalis. Tetrahedron Lett. 2001;42(46):8223–5. - 51.
Devasagayam T, Tilak J, Boloor K, Sane K, Ghaskadbi S, Lele R. Free radicals and antioxidants in human health: current status and future prospects. Assoc Physicians India. 2004;52:794–804. - 52.
Shi Y, Yao S, Zhongjian J, Nianyun L, Rongliang Z. Dietary polyphenols act as scavengers of reducing radicals. Food Chem. 2011;124:1322–7. - 53.
Hammes WP, Hertel C. The genera lactobacillus and carnobacterium. In: The Prokaryotes [Internet]. New York, NY: Springer US; 2006. p. 320–403. Available from: http://link.springer.com/10.1007/0-387-30744-3_10. - 54.
Canchaya C, Claesson MJ, Fitzgerald GF, van Sinderen D, O’Toole PW. Diversity of the genus Lactobacillus revealed by comparative genomics of five species. Microbiology [Internet]. 2006;152(Pt 11):3185–96. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17074890. - 55.
Claesson MJ, van Sinderen D, O’Toole PW. The genus Lactobacillus—genomic basis for understanding its diversity. FEMS Microbiol Lett [Internet]. 2007;269(1):22–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17343688. - 56.
Walter J. Ecological role of lactobacilli in the gastrointestinal tract: implications for fundamental and biomedical research. Appl Environ Microbiol [Internet]. 2008;74(16):4985–96. Available from: http://aem.asm.org/cgi/doi/10.1128/AEM.00753-08. - 57.
Gustafsson RJ, Ahrné S, Jeppsson B, Benoni C, Olsson C, Stjernquist M, et al. The Lactobacillus flora in vagina and rectum of fertile and postmenopausal healthy Swedish women. BMC Womens Health [Internet]. 2011;11(1):17. Available from: http://www.biomedcentral.com/1472-6874/11/17. - 58.
Pot B, Felis GE, Bruyne K De, Tsakalidou E, Papadimitriou K, Leisner J, et al. The genus Lactobacillus. In: Holzapfel WH, Wood BJB, editors. Lactic Acid Bacteria [Internet]. Chichester, UK: John Wiley & Sons, Ltd; 2014. p. 249–353. Available from: http://doi.wiley.com/10.1002/9781118655252. - 59.
Huttenhower C, Gevers D, Knight R, Abubucker S, Badger JH, Chinwalla AT, et al. Structure, function and diversity of the healthy human microbiome. Nature [Internet]. 2012;486(7402):207–14. Available from: http://www.nature.com/doifinder/10.1038/nature11234. - 60.
Forsum U, Holst E, Larsson PG, Vasquez A, Jakobsson T, Mattsby-Baltzer I. Bacterial vaginosis – a microbiological and immunological enigma. APMIS [Internet]. 2005;113(2):81–90. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15723682. - 61.
Petrova MI, Lievens E, Malik S, Imholz N, Lebeer S. Lactobacillus species as biomarkers and agents that can promote various aspects of vaginal health. Front Physiol [Internet]. 2015;6:81. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25859220. - 62.
Valladares RB, Graves C, Wright K, Gardner CL, Lorca GL, Gonzalez CF. H2O2 production rate in Lactobacillus johnsonii is modulated via the interplay of a heterodimeric flavin oxidoreductase with a soluble 28 Kd PAS domain containing protein. Front Microbiol [Internet]. 2015;6(July):1–14. Available from: http://journal.frontiersin.org/Article/10.3389/fmicb.2015.00716/abstract. - 63.
Hayashi H, Sakamoto M, Benno Y. Phylogenetic analysis of the human gut microbiota using 16S rDNA clone libraries and strictly anaerobic culture-based methods. Microbiol Immunol [Internet]. 2002;46(8):535–48. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12363017. - 64.
Hayashi H, Takahashi R, Nishi T, Sakamoto M, Benno Y. Molecular analysis of jejunal, ileal, caecal and recto-sigmoidal human colonic microbiota using 16S rRNA gene libraries and terminal restriction fragment length polymorphism. J Med Microbiol [Internet]. 2005;54(Pt 11):1093–101. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16192442. - 65.
Wang M, Ahrné S, Jeppsson B, Molin G. Comparison of bacterial diversity along the human intestinal tract by direct cloning and sequencing of 16S rRNA genes. FEMS Microbiol Ecol [Internet]. 2005;54(2):219–31. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16332321. - 66.
Ley RE, Turnbaugh PJ, Klein S, Gordon JI. Microbial ecology: human gut microbes associated with obesity. Nature [Internet]. 2006;444(7122):1022–3. Available from: http://www.nature.com/doifinder/10.1038/4441022a. - 67.
Moon S-K, Wee Y-J, Choi G-W. A novel lactic acid bacterium for the production of high purity L-lactic acid, Lactobacillus paracasei subsp. paracasei CHB2121. J Biosci Bioeng [Internet]. 2012;114(2):155–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22578598. - 68.
Steele J, Broadbent J, Kok J. Perspectives on the contribution of lactic acid bacteria to cheese flavor development. Curr Opin Biotechnol [Internet]. 2013;24(2):135–41. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23279928. - 69.
Hertzberger R, Arents J, Dekker HL, Pridmore RD, Gysler C, Kleerebezem M, et al. H2O2 production in species of the Lactobacillus acidophilus group: a central role for a novel NADH-dependent flavin reductase. Appl Environ Microbiol [Internet]. 2014;80(7):2229–39. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24487531. - 70.
Yang T, Wu K, Wang F, Liang X, Liu Q, Li G, et al. Effect of exopolysaccharides from lactic acid bacteria on the texture and microstructure of buffalo yoghurt. Int Dairy J [Internet]. 2014;34(2):252–6. Available from: http://linkinghub.elsevier.com/retrieve/pii/S0958694613002239. - 71.
Dobson A, Cotter PD, Ross RP, Hill C. Bacteriocin production: a probiotic trait? Appl Environ Microbiol [Internet]. 2012;78(1):1–6. Available from: http://aem.asm.org/cgi/doi/10.1128/AEM.05576-11. - 72.
Baick S-C, Kim C-H. Assessment of characteristics and functional properties of lactobacillus species isolated from kimchi for dairy use. Korean J food Sci Anim Resour [Internet]. 2015;35(3):339–49. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26761848. - 73.
Sharma R, Sanodiya BS, Bagrodia D, Pandey M, Sharma A, Bisen PS. Efficacy and potential of lactic acid bacteria modulating human health. Int J Pharma Bio Sci. 2012;3(4):935–48. - 74.
Beganović J, Kos B, Leboš Pavunc A, Uroić K, Džidara P, Šušković J. Proteolytic activity of probiotic strain Lactobacillus helveticus M92. Anaerobe [Internet]. 2013;20:58–64. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23454496. - 75.
Todorov SD, Rachman C, Fourrier A, Dicks LMT, van Reenen CA, Prévost H, et al. Characterization of a bacteriocin produced by Lactobacillus sakei R1333 isolated from smoked salmon. Anaerobe [Internet]. 2011;17(1):23–31. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20152920. - 76.
Svetoch EA, Eruslanov BV, Levchuk VP, Perelygin VV, Mitsevich EV, Mitsevich IP, et al. Isolation of Lactobacillus salivarius 1077 (NRRL B-50053) and characterization of its bacteriocin, including the antimicrobial activity spectrum. Appl Environ Microbiol [Internet]. 2011;77(8):2749–54. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21378051. - 77.
Kanatani K, Oshimura M, Sano K. Isolation and characterization of acidocin A and cloning of the bacteriocin gene from Lactobacillus acidophilus. Appl Environ Microbiol [Internet]. 1995;61(3):1061–7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/7793908. - 78.
Donaghy J, Kelly PF, McKay AM. Detection of ferulic acid esterase production by Bacillus spp. and lactobacilli. Appl Microbiol Biotechnol [Internet]. 1998;50(2):257–60. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9763694. - 79.
Guglielmetti S, De Noni I, Caracciolo F, Molinari F, Parini C, Mora D. Bacterial cinnamoyl esterase activity screening for the production of a novel functional food product. Appl Environ Microbiol [Internet]. 2008;74(4):1284–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18165367. - 80.
Couteau D, McCartney AL, Gibson GR, Williamson G, Faulds CB. Isolation and characterization of human colonic bacteria able to hydrolyse chlorogenic acid. J Appl Microbiol [Internet]. 2001;90(6):873–81. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11412317. - 81.
Esteban-Torres M, Reverón I, Mancheño JM, de Las Rivas B, Muñoz R. Characterization of a feruloyl esterase from Lactobacillus plantarum. Appl Environ Microbiol [Internet]. 2013;79(17):5130–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23793626. - 82.
Esteban-Torres M, Landete JM, Reverón I, Santamaría L, de las Rivas B, Muñoz R. A Lactobacillus plantarum esterase active on a broad range of phenolic esters. Appl Environ Microbiol [Internet]. 2015;81(9):3235–42. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25746986. - 83.
Balasubashini MS, Rukkumani R, Viswanathan P, Menon VP. Ferulic acid alleviates lipid peroxidation in diabetic rats. Phytother Res [Internet]. 2004;18(4):310–4. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15162367. - 84.
Gonthier M-P, Remesy C, Scalbert A, Cheynier V, Souquet J-M, Poutanen K, et al. Microbial metabolism of caffeic acid and its esters chlorogenic and caftaric acids by human faecal microbiota in vitro. Biomed Pharmacother = Biomédecine pharmacothérapie [Internet]. 2006;60(9):536–40. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16978827. - 85.
Pagella JH, Chen XB, MacLeod NA, Orskov ER, Dewey PJ. Excretion of benzoic acid derivatives in urine of sheep given intraruminal infusions of 3-phenylpropionic and cyclohexanecarboxylic acids. Br J Nutr [Internet]. 1997;77(4):577–92. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9155507. - 86.
Chesson A, Provan GJ, Russell WR, Scobbie L, Richardson AJ, Stewart C. Hydroxycinnamic acids in the digestive tract of livestock and humans. J Sci Food Agric [Internet]. 1999;79(3):373–8. Available from: http://doi.wiley.com/10.1002/%28SICI%291097-0010%2819990301%2979%3A3%3C373%3A%3AAID-JSFA257%3E3.0.CO%3B2-6. - 87.
Ankolekar C, Johnson K, Pinto M, Johnson D, Labbe RG, Greene D, et al. Fermentation of whole apple juice using lactobacillus acidophilus for potential dietary management of hyperglycemia, hypertension, and modulation of beneficial bacterial responses. J Food Biochem [Internet]. 2012;36(6):718–38. Available from: http://doi.wiley.com/10.1111/j.1745-4514.2011.00596.x. - 88.
Huynh N, Van Camp J, Smagghe G, Raes K. Improved release and metabolism of flavonoids by steered fermentation processes: a review. Int J Mol Sci [Internet]. 2014;15(11):19369–88. Available from: http://www.mdpi.com/1422-0067/15/11/19369/. - 89.
Hole AS, Rud I, Grimmer S, Sigl S, Narvhus J, Sahlstrøm S. Improved bioavailability of dietary phenolic acids in whole grain barley and oat groat following fermentation with probiotic Lactobacillus acidophilus, Lactobacillus johnsonii, and Lactobacillus reuteri. J Agric Food Chem [Internet]. 2012;60(25):6369–75. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22676388. - 90.
Bel-Rhlid R, Thapa D, Kraehenbuehl K, Hansen CE, Fischer L. Biotransformation of caffeoyl quinic acids from green coffee extracts by Lactobacillus johnsonii NCC 533. AMB Express [Internet]. 2013;3:28. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23692950. - 91.
Bel-Rhlid R, Crespy V, Pagé-Zoerkler N, Nagy K, Raab T, Hansen C-E. Hydrolysis of rosmarinic acid from rosemary extract with esterases and Lactobacillus johnsonii in vitro and in a gastrointestinal model. J Agric Food Chem [Internet]. 2009;57(17):7700–5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19658402. - 92.
Curiel JA, Rodríguez H, Landete JM, de las Rivas B, Muñoz R. Ability of Lactobacillus brevis strains to degrade food phenolic acids. Food Chem [Internet]. 2010;120(1):225–9. Available from: http://linkinghub.elsevier.com/retrieve/pii/S030881460901190X. - 93.
Muniandy P, Shori AB, Baba AS. Comparison of the effect of green, white and black tea on Streptococcus thermophilus and Lactobacillus spp. in yogurt during refrigerated storage. J Assoc Arab Univ Basic Appl Sci [Internet]. 2015; Available from: http://linkinghub.elsevier.com/retrieve/pii/S1815385215000334. - 94.
Michael M, Phebus RK, Schmidt KA. Plant extract enhances the viability of Lactobacillus delbrueckii subsp. bulgaricus and Lactobacillus acidophilus in probiotic nonfat yogurt. Food Sci Nutr [Internet]. 2015;3(1):48–55. Available from: http://doi.wiley.com/10.1002/fsn3.189. - 95.
Brugman S, Klatter FA, Visser JTJ, Wildeboer-Veloo ACM, Harmsen HJM, Rozing J, et al. Antibiotic treatment partially protects against type 1 diabetes in the Bio-Breeding diabetes-prone rat. Is the gut flora involved in the development of type 1 diabetes? Diabetologia [Internet]. 2006;49(9):2105–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16816951. - 96.
Schwartz RF, Neu J, Schatz D, Atkinson MA, Wasserfall C. Comment on: Brugman S et al. (2006) Antibiotic treatment partially protects against type 1 diabetes in the Bio-Breeding diabetes-prone rat. Is the gut flora involved in the development of type 1 diabetes? Diabetologia 49:2105–2108. Diabetologia [Internet]. 2007;50(1):220–1. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17119915. - 97.
Neu J, Reverte CM, Mackey AD, Liboni K, Tuhacek-Tenace LM, Hatch M, et al. Changes in intestinal morphology and permeability in the biobreeding rat before the onset of type 1 diabetes. J Pediatr Gastroenterol Nutr [Internet]. 2005;40(5):589–95. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15861021. - 98.
Caicedo RA, Li N, Des Robert C, Scumpia PO, Hubsher CP, Wasserfall CH, et al. Neonatal formula feeding leads to immunological alterations in an animal model of type 1 diabetes. Pediatr Res [Internet]. 2008;63(3):303–7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18091354. - 99.
National Diabates Statistics Report, 2014 [Internet]. Centers of Disease Control and Prevention. 2014 [cited 2015 Jan 1]. Available from: http://www.cdc.gov/diabetes/pubs/statsreport14/national-diabetes-report-web.pdf. - 100.
Prime Group for JDRF [Internet]. 2011 [cited 2015 Jan 1]. Available from: http://www2.jdrf.org/site/DocServer/KW-T1D_Factsheet.pdf?docID=1024. - 101.
Patterson CC, Gyürüs E, Rosenbauer J, Cinek O, Neu A, Schober E, et al. Trends in childhood type 1 diabetes incidence in Europe during 1989–2008: evidence of non-uniformity over time in rates of increase. Diabetologia [Internet]. 2012;55(8):2142–7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22638547. - 102.
Bell RA, Mayer-Davis EJ, Beyer JW, D’Agostino RB, Lawrence JM, Linder B, et al. Diabetes in non-Hispanic white youth: prevalence, incidence, and clinical characteristics: the SEARCH for Diabetes in Youth Study. Diabetes Care [Internet]. 2009;32(Suppl 2):S102–11. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19246575. - 103.
Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C, et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature [Internet]. 2010;464(7285):59–65. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20203603. - 104.
Roesch LFW, Lorca GL, Casella G, Giongo A, Naranjo A, Pionzio AM, et al. the Onset Diabet Rat Model. 2010;3(5):536–48. - 105.
Malaguti C, La Guardia PG, Leite ACR, Oliveira DN, de Lima Zollner RL, Catharino RR, et al. Oxidative stress and susceptibility to mitochondrial permeability transition precedes the onset of diabetes in autoimmune non-obese diabetic mice. Free Radic Res [Internet]. 2014;48(12):1494–504. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25236567. - 106.
Babu PVA, Liu D, Gilbert ER. Recent advances in understanding the anti-diabetic actions of dietary flavonoids. J Nutr Biochem [Internet]. 2013;24(11):1777–89. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24029069. - 107.
Lightfoot YL, Chen J, Mathews CE. Oxidative stress and beta cell dysfunction. Methods Mol Biol [Internet]. 2012;900:347–62. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22933078. - 108.
Balasubashini MS, Rukkumani R, Menon VP. Protective effects of ferulic acid on hyperlipidemic diabetic rats. Acta Diabetol. 2003;40:118–22. - 109.
Adisakwattana S, Moonsan P, Yibchok-Anun S. Insulin-releasing properties of a series of cinnamic acid derivatives in vitro and in vivo. J Agric Food Chem [Internet]. 2008;56(17):7838–44. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18651742. - 110.
Valladares R, Sankar D, Li N, Williams E, Lai K-K, Abdelgeliel AS, et al. Lactobacillus johnsonii N6.2 mitigates the development of type 1 diabetes in BB-DP rats. PLoS One [Internet]. 2010;5(5):e10507. Available from:/pmc/articles/PMC2865539/?report=abstract. - 111.
Crepin VF, Faulds CB, Connerton IF. Production and characterization of the Talaromyces stipitatus feruloyl esterase FAEC in Pichia pastoris: identification of the nucleophilic serine. Protein Expr Purif [Internet]. 2003;29(2):176–84. Available from: http://linkinghub.elsevier.com/retrieve/pii/S1046592803000500. - 112.
Lai K-K, Stogios PJ, Vu C, Xu X, Cui H, Molloy S, et al. An inserted α/β subdomain shapes the catalytic pocket of Lactobacillus johnsonii cinnamoyl esterase. PLoS One [Internet]. 2011;6(8):e23269. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21876742. - 113.
Elamin E, Masclee A, Juuti-Uusitalo K, van Ijzendoorn S, Troost F, Pieters H-J, et al. Fatty acid ethyl esters induce intestinal epithelial barrier dysfunction via a reactive oxygen species-dependent mechanism in a three-dimensional cell culture model. PLoS One [Internet]. 2013;8(3):e58561. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23526996. - 114.
Tate DJ, Patterson JR, Velasco-Gonzalez C, Carroll EN, Trinh J, Edwards D, et al. Interferon-gamma-induced nitric oxide inhibits the proliferation of murine renal cell carcinoma cells. Int J Biol Sci [Internet]. 2012;8(8):1109–20. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22991499. - 115.
Riquelme P, Tomiuk S, Kammler A, Fändrich F, Schlitt HJ, Geissler EK, et al. IFN-γ-induced iNOS expression in mouse regulatory macrophages prolongs allograft survival in fully immunocompetent recipients. Mol Ther [Internet]. 2013;21(2):409–22. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22929659. - 116.
Kingma SDK, Li N, Sun F, Valladares RB, Neu J, Lorca GL. Lactobacillus johnsonii N6.2 Stimulates the innate immune response through Toll-Like receptor 9 in Caco-2 cells and increases intestinal crypt Paneth cell number in biobreeding diabetes-prone rats. J Nutr. 2011;1–3:4–9. - 117.
van Es JH, Jay P, Gregorieff A, van Gijn ME, Jonkheer S, Hatzis P, et al. Wnt signalling induces maturation of Paneth cells in intestinal crypts. Nat Cell Biol [Internet]. 2005;7(4):381–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15778706. - 118.
Veckman V, Miettinen M, Pirhonen J, Sirén J, Matikainen S, Julkunen I. Streptococcus pyogenes and Lactobacillus rhamnosus differentially induce maturation and production of Th1-type cytokines and chemokines in human monocyte-derived dendritic cells. J Leukoc Biol [Internet]. 2004;75(5):764–71. Available from: http://www.ncbi.nlm.nih.gov/pubmed/14966192. - 119.
Hilbert T, Bongartz J, Weisheit C, Knüfermann P, Baumgarten G, Hoeft A, et al. Beta2-adrenoceptor stimulation suppresses TLR9-dependent IFNA1 secretion in human peripheral blood mononuclear cells. PLoS One [Internet]. 2013;8(5):e65024. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23724117. - 120.
Lau K, Benitez P, Ardissone A, Wilson TD, Collins EL, Lorca G, et al. Inhibition of type 1 diabetes correlated to a Lactobacillus johnsonii N6.2-mediated Th17 bias. J Immunol [Internet]. 2011;186(6):3538–46. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21317395. - 121.
Opitz CA, Litzenburger UM, Sahm F, Ott M, Tritschler I, Trump S, et al. An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor. Nature [Internet]. 2011;478(7368):197–203. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21976023. - 122.
Bessede A, Gargaro M, Pallotta MT, Matino D, Servillo G, Brunacci C, et al. Aryl hydrocarbon receptor control of a disease tolerance defence pathway. Nature [Internet]. 2014;511(7508):184–90. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24930766. - 123.
Denison MS, Nagy SR. Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals. Annu Rev Pharmacol Toxicol [Internet]. 2003;43(1):309–34. Available from: http://www.annualreviews.org/doi/abs/10.1146/annurev.pharmtox.43.100901.135828. - 124.
Vogel CFA, Goth SR, Dong B, Pessah IN, Matsumura F. Aryl hydrocarbon receptor signaling mediates expression of indoleamine 2,3-dioxygenase. Biochem Biophys Res Commun [Internet]. 2008;375(3):331–5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18694728. - 125.
Jux B, Kadow S, Esser C. Langerhans cell maturation and contact hypersensitivity are impaired in aryl hydrocarbon receptor-null mice. J Immunol [Internet]. 2009;182(11):6709–17. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19454665. - 126.
Nguyen NT, Kimura A, Nakahama T, Chinen I, Masuda K, Nohara K, et al. Aryl hydrocarbon receptor negatively regulates dendritic cell immunogenicity via a kynurenine-dependent mechanism. Proc Natl Acad Sci U S A [Internet]. 2010;107(46):19961–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21041655. - 127.
Monteleone I, Rizzo A, Sarra M, Sica G, Sileri P, Biancone L, et al. Aryl hydrocarbon receptor-induced signals up-regulate IL-22 production and inhibit inflammation in the gastrointestinal tract. Gastroenterology [Internet]. 2011;141(1):237–48, 248.e1. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21600206. - 128.
Veldhoen M, Hirota K, Westendorf AM, Buer J, Dumoutier L, Renauld J-C, et al. The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins. Nature [Internet]. 2008;453(7191):106–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18362914. - 129.
Nakahama T, Kimura A, Nguyen NT, Chinen I, Hanieh H, Nohara K, et al. Aryl hydrocarbon receptor deficiency in T cells suppresses the development of collagen-induced arthritis. Proc Natl Acad Sci U S A [Internet]. 2011;108(34):14222–7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21825138. - 130.
Valladares R, Bojilova L, Potts AH, Cameron E, Gardner C, Lorca G, et al. Lactobacillus johnsonii inhibits indoleamine 2,3-dioxygenase and alters tryptophan metabolite levels in BioBreeding rats. FASEB J [Internet]. 2013;27(4):1711–20. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23303207. - 131.
Pilotte L, Larrieu P, Stroobant V, Colau D, Dolusic E, Frédérick R, et al. Reversal of tumoral immune resistance by inhibition of tryptophan 2,3-dioxygenase. Proc Natl Acad Sci U S A [Internet]. 2012;109(7):2497–502. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22308364. - 132.
Freewan M, Rees MD, Plaza TSS, Glaros E, Lim YJ, Wang XS, et al. Human indoleamine 2,3-dioxygenase is a catalyst of physiological heme peroxidase reactions: implications for the inhibition of dioxygenase activity by hydrogen peroxide. J Biol Chem [Internet]. 2013;288(3):1548–67. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23209301. - 133.
Godbout JP, Moreau M, Lestage J, Chen J, Sparkman NL, O’Connor J, et al. Aging exacerbates depressive-like behavior in mice in response to activation of the peripheral innate immune system. Neuropsychopharmacology [Internet]. 2008;33(10):2341–51. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18075491. - 134.
Corona AW, Norden DM, Skendelas JP, Huang Y, O’Connor JC, Lawson M, et al. Indoleamine 2,3-dioxygenase inhibition attenuates lipopolysaccharide induced persistent microglial activation and depressive-like complications in fractalkine receptor (CX(3)CR1)-deficient mice. Brain Behav Immun [Internet]. 2013;31:134–42. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22926082. - 135.
Shibata Y, Hara T, Nagano J, Nakamura N, Ohno T, Ninomiya S, et al. The role of indoleamine 2,3-dioxygenase in diethylnitrosamine-induced liver carcinogenesis. PLoS One [Internet]. 2016;11(1):e0146279. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26727596. - 136.
Masaki A, Ishida T, Maeda Y, Suzuki S, Ito A, Takino H, et al. Prognostic significance of tryptophan catabolism in adult T-cell leukemia/lymphoma. [Rinshō ketsueki] Japanese J Clin Hematol [Internet]. 2015;56(11):2295–304. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26666715. - 137.
Ben-Haj-Ayed A, Moussa A, Ghedira R, Gabbouj S, Miled S, Bouzid N, et al. Prognostic value of indoleamine 2,3-dioxygenase activity and expression in nasopharyngeal carcinoma. Immunol Lett [Internet]. 2016;169:23–32. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26608400.